The controversy about cognitive behavioural therapy for schizophrenia

The effectiveness of cognitive behavioural therapy (CBT) in schizophrenia is currently disputed. For example, the UK National Institute for Health and Care Excellence (NICE)1 recommends this therapy, whereas another influential UK organization, the Cochrane Collaboration, has argued since 2012 that there is no clear evidence that it is effective2, 3, 4